Major Micro-Cap Stock Insider Selling: Pixelworks (NASDAQ:PXLW), Emmis Communications (NASDAQ:EMMS), Pernix Therapeutics (NYSE:PTX) & Intermolecular (NASDAQ:IMI)

Pixelworks (NASDAQ:PXLW) CEO Bruce A. Walicek sold 12,000 shares of the stock in a transaction dated Thursday, April 10th. The shares were sold at an average price of $6.10, for a total value of $73,200.00. Following the transaction, the chief executive officer now directly owns 393,205 shares in the company, valued at approximately $2,398,551. Pixelworks, Inc. (NASDAQ:PXLW) shares after opening at $5.46 on last trade day and at the end of the day closed at $5.43. Company price to sales ratio in past twelve months was calculated as 2.53 and price to cash ratio as 5.86. Pixelworks, Inc. (NASDAQ:PXLW) showed a positive weekly performance of 7.31%.

Emmis Communications (NASDAQ:EMMS) Director Gary L. Kaseff sold 32,200 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $3.23, for a total value of $104,006.00. Following the completion of the sale, the director now directly owns 303,847 shares in the company, valued at approximately $981,426. Emmis Communications Corporation (NASDAQ:EMMS) shares advanced 0.96% in last trading session and ended the day on $3.14. EMMS return on equity ratio is recorded as -372.70% and its return on assets is 5.70%. Emmis Communications Corporation (NASDAQ:EMMS) yearly performance is 97.48%.

Pernix Therapeutics Holdings (NYSE:PTX) major shareholder James Edward Jr. Smith sold 45,000 shares of Pernix Therapeutics Holdings stock on the open market in a transaction dated Monday, April 7th. The stock was sold at an average price of $4.90, for a total value of $220,500.00. Following the sale, the insider now directly owns 4,612,704 shares of the company’s stock, valued at approximately $22,602,250. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shares moved up 2.04% in last trading session and was closed at $4.99, while trading in range of $4.75 – $5.15. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) year to date (YTD) performance is 98.02%.

Intermolecular (NASDAQ:IMI) SVP Raj Jammy sold 5,356 shares of the stock on the open market in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $2.76, for a total transaction of $14,782.56. Following the completion of the sale, the senior vice president now directly owns 59,644 shares of the company’s stock, valued at approximately $164,617. Intermolecular Inc (NASDAQ:IMI) weekly performance is -3.21%. On last trading day company shares ended up $2.71. Intermolecular Inc (NASDAQ:IMI) distance from 50-day simple moving average (SMA50) is -16.32%. Analysts mean target price for the company is $9.00.